Bio-Rad Laboratories, Inc.
(NYSE : BIO)

( )
BIO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.31%610.121.0%$825.30m
DHRDanaher Corp. -0.21%324.360.7%$642.83m
ABTAbbott Laboratories -0.77%124.340.8%$542.57m
ISRGIntuitive Surgical, Inc. -0.15%1043.332.3%$528.28m
MDTMedtronic Plc -0.41%130.110.6%$463.90m
BDXBecton, Dickinson & Co. -0.21%253.281.0%$354.78m
ALGNAlign Technology, Inc. -0.26%725.246.3%$347.10m
BAXBaxter International, Inc. 0.12%80.891.8%$318.77m
IDXXIDEXX Laboratories, Inc. -0.43%679.643.8%$308.74m
DXCMDexCom, Inc. -2.09%560.747.8%$295.30m
HRCHill-Rom Holdings, Inc. -0.27%149.962.2%$293.62m
SYKStryker Corp. 0.23%276.801.3%$282.69m
BSXBoston Scientific Corp. -0.76%44.661.0%$258.58m
ZBHZimmer Biomet Holdings, Inc. 0.45%151.071.7%$237.68m
AAgilent Technologies, Inc. -0.26%172.321.6%$230.65m

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.